Lakefront Biotherapeutics (LKFT) Goodwill (2013 - 2025)

Lakefront Biotherapeutics (LKFT) has reported Goodwill for 13 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill fell 95.63% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 95.63% YoY), while the FY2025 annual figure was $3.5 million, down 95.34% from the prior year.
• Goodwill slipped to $3.2 million in Q1 2026 per LKFT's latest filing, from $3.5 million in the prior quarter.
• Across five years, Goodwill topped out at $78.3 million in Q2 2025 and bottomed at -$1.9 million in Q1 2022.
• Historically, Goodwill has averaged $52.6 million across 5 years, with a median of $74.8 million in 2023.
• Annual changes were most pronounced in 2023 — Goodwill soared 4047.3% — and 2026, when it plunged 95.63%.
• Lakefront Biotherapeutics' Goodwill stood at $71.2 million in 2022, then increased by 5.07% to $74.8 million in 2023, then retreated by 0.04% to $74.8 million in 2024, then plunged by 95.34% to $3.5 million in 2025, then fell by 8.22% to $3.2 million in 2026.
• Business Quant data shows LKFT's Goodwill at $3.2 million in Q1 2026, $3.5 million in Q4 2025, and $3.6 million in Q3 2025.